Overall, our study demonstrates the multiple potentials of DDR1 in the immunotherapy of gastric cancer, including immune infiltration and tumor invasion, and also expands the direction of DDR1 signaling mechanism research. The gene discussed is DDR1; the disease is neoplasm.